Pacer Advisors, Inc. Inari Medical, Inc. Transaction History

Pacer Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$40.65 - $65.76 $2,682 - $4,340	-66 Reduced 0.86%	7,622 $365,000
Q4 2023 Jan 16, 2024	BUY	$48.3 - $68.06 $164,799 - $232,220	3,412 Added 79.79%	7,688 $499,000
Q3 2023 Nov 13, 2023	SELL	$54.2 - $71.67 $520,049 - $687,673	-9,595 Reduced 69.17%	4,276 $279,000
Q2 2023 Jul 12, 2023	BUY	$56.23 - $71.17 $400,413 - $506,801	7,121 Added 105.5%	13,871 $806,000
Q1 2023 May 02, 2023	SELL	$53.43 - $68.12 $133,361 - $170,027	-2,496 Reduced 27.0%	6,750 $416,000
Q4 2022 Feb 06, 2023	BUY	$61.23 - $83.62 $268,799 - $367,091	4,390 Added 90.4%	9,246 $587,000
Q3 2022 Oct 18, 2022	BUY	$65.58 - $84.69 $318,456 - $411,254	4,856 New	4,856 $353,000

261

56.2M

90.4K

27.3K

Ticker NARI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,389,700
Market Cap $2.96B
Description
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.